Pfizer Stories | Articles & Content Features

Go To Section

Articles
Behind the Science Features
Podcasts
eBooks
Subscriptions

Articles

Direct Relief and The Pfizer Foundation Expand Support for Community Health Centers on the Front Lines of Infectious Disease Care

Credit: Direct ReliefThis spring, Direct Relief and The Pfizer Foundation announced the third cohort of the Innovation Awards in Community Health, marking five years of support for community health centers working to strengthen infectious disease prevention, education, screening, testing, treatment, and care in medically underserved communities. Through $4.5 million in grants distributed over two years, the latest program cohort includes 16 U.S. safety-net community health organizations across....

How Pfizer Thinks About AI

At Pfizer, our ambition is to be the most AI-forward company in our industry, and we are making great progress every day. I spend more time thinking about it than almost anything else because I believe this is an unprecedented opportunity. AI will fundamentally improve how we discover medicines, how we develop and manufacture them and how quickly we reach patients. Very few technologies can change every corner of a business in this way.AI adoption is one thing — nearly every company has done it....

Beyond the Breakthrough: The Manufacturing Work That Gets Medicines and Vaccines to Patients

Scientific discoveries form the basis of every medical breakthrough. But transforming those discoveries into medicines that reach patients requires another kind of innovation: manufacturing.Behind every dose, a complex global network of manufacturing sites, supply chain experts, quality teams, and logistics specialists work together to produce medicines consistently, reliably, and at the scale patients need. These efforts often happen behind the scenes, but they play a critical role in expanding....

July Social Media Round-Up—America 250, Pfizer Futures, and More

Even amidst the cookouts, fireworks, and vacations, Pfizer remains hard at work all summer long, and July was no different.Last month, we held important conversations around living with alopecia areata, shared the story of a Pfizer colleague and cancer survivor, and reflected on the changes in science over the years.CEO Albert Bourla celebrated America’s 250th birthday, shared advice for our outgoing Pfizer Futures class, and congratulated the World Cup winners. While our leadership team shared....

Exploring the Latest Advances in Menstrual Migraine Research

For millions of people who menstruate, migraine attacks don’t always strike at random. For many, they’re more likely to occur in and around the days of the menstrual period, driven in part by the hormonal shifts of the cycle. When migraine attacks consistently occur on or around menstruation, the pattern has a name—menstrual migraine—and it’s more than just a bad headache.Research suggests migraine attacks that occur during the menstrual period are often more disabling relative to those that....

8 Lessons I’ve Learned as a Cancer Survivor

For most of my life I’ve lived by the belief that everything happens for a reason. The challenge is that I don’t always know what that reason is. That was certainly the case two years ago, when I was diagnosed with Leiomyosarcoma.It took a long time for me to learn what was making me sick. After searching for answers, an MRI revealed a large tumor deep in my abdomen. Following surgery to remove it, I learned that I had a rare and aggressive cancer that grows in the body’s soft tissues. Still, it....

Then vs. Now: Flow Chemistry

The way medicines are made has changed significantly over time. Many of today’s drug molecules are larger and more complex than those developed decades ago and the methods for synthesis have evolved accordingly. As chemists design increasingly sophisticated molecules, they also need more precise and flexible ways to carry out the reactions that produce them.For much of history, chemists have carried out reactions in static vessels such as flasks in the lab or large reactors in manufacturing....

Then vs. Now: Molecular Design

Developing a new medicine starts at the most fundamental level: understanding how disease works. That often means looking beyond what we can observe directly and studying how molecules interact with biological targets.Much of what drives disease and how we treat it happens at a scale too small to see. In drug discovery, scientists study how molecules find, bind to, and influence their targets. The strength and specificity of these interactions play a critical role in determining how effective a....

June Social Media Round-Up—2025 Impact Report, ADA 2026, and More

School is out for the summer, but Pfizer colleagues are still hard at work. In June, we released our 2025 Impact Report, shared risks of fake medicines on World Anti-Counterfeit Day, and raised awareness of menstrual-related migraine and more.Pfizer has also been present at many conferences this past month—from ASCO and ADA to EHA and AHS 2026, and our leadership team has been highlighting the latest data that we’ve shared at these events. Meanwhile, CEO Albert Bourla joined the CNBC CEO Council....

Behind the Science Features

What are ADCs? Targeting cancer with special drug delivery units

For centuries, humanity has hoped for a world where people with cancer live better, longer lives – and today that vision is closer than ever. Learn how antibody drug conjugates (ADCs) are emerging as one of the most powerful tools in cancer treatment.

Ever Wonder How Drugs Get Their Names?

Naming medications is not a simple process. It's a collaborative, conscientious effort, and one that is both an art and a science. Take a peek behind the curtain to see how drugs are named.

Understanding Obesity as a Complex Disease

Some people think obesity is simply caused by unhealthy eating habits and not exercising enough. But, in fact, the scientific and medical community defines obesity as a complex, multifactoral chronic disease.

See more Behind the Science Features